Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Feb 3, 2017

29745_dirs_2017-02-03_b4e48fd0-f353-44d1-bc3d-0349001c16d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-02-01

Reporting Person: Rice Derica W (EVP-Global Services and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-01 Common Stock M 19463 Acquired 58443 Direct
2017-02-01 Common Stock F 8989 $77.03 Disposed 49454 Direct
2017-02-02 Common Stock S 7270 $76.97 Disposed 42184 Direct
2017-02-03 Common Stock S 3892 $77.47 Disposed 38292 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-01 Restricted Stock Unit $ M 19463 Disposed 2017-02-01 Common Stock (19463.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7394 Indirect
Common Stock 365659 Indirect
Common Stock 1905 Indirect

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 8, 2016.

F2: Reporting person disclaims beneficial ownership of these shares.

F3: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.